Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Accured Expenses: 2010-2025

Historic Change in Accured Expenses for Prestige Consumer Healthcare (PBH) over the last 16 years, with Mar 2025 value amounting to $7.0 million.

  • Prestige Consumer Healthcare's Change in Accured Expenses rose 79.05% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year increase of 366.81%. This contributed to the annual value of $7.0 million for FY2025, which is 143.07% up from last year.
  • Prestige Consumer Healthcare's Change in Accured Expenses amounted to $7.0 million in FY2025, which was up 143.07% from -$16.2 million recorded in FY2024.
  • Prestige Consumer Healthcare's Change in Accured Expenses' 5-year high stood at $10.7 million during FY2023, with a 5-year trough of -$16.2 million in FY2024.
  • Its 3-year average for Change in Accured Expenses is $503,000, with a median of $7.0 million in 2025.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 164.48% in 2022, then tumbled by 250.97% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Change in Accured Expenses (MRY) stood at -$14.9 million in 2021, then soared by 164.48% to $9.6 million in 2022, then grew by 11.71% to $10.7 million in 2023, then plummeted by 250.97% to -$16.2 million in 2024, then skyrocketed by 143.07% to $7.0 million in 2025.
  • Its Change in Accured Expenses was $7.0 million in FY2025, compared to -$16.2 million in FY2024 and $10.7 million in FY2023.